Unprecedented biobanking effort to combat COVID-19

Oct 28, 2020 | Conduits News

In April 2nd, at the peak of the COVID-19 surge, the Mount Sinai Health System (MSHS) announced the launch of an unprecedented biobanking effort to combat COVID-19. The goal was to rapidly collect blood samples from hundreds of COVID-19 patients admitted to MSHS to serve as the backbone for COVID-19 research. Embarking together as healthcare workers and scientists on a bold endeavor was precisely what the moment demanded.

Thanks to a volunteer team of over 100 research staff, nurses, doctors, and scientists, this initiative was a resounding success. Led by the Mount Sinai Clinical Intelligence Center (MSCIC) and the Human Immune Monitoring Center (HIMC), teams were organized for screening electronic medical records, obtaining informed consent, assembling collection kits, performing nurse outreach, transporting specimens, processing samples, biobanking, molecular data generation, bioinformatics analysis, and overall project management. Carried out in a fog-of-war environment, this effort formed a blueprint (1) for implementing large-scale research on COVID-19 patients in a health system under siege. Over a one-month span at the peak of the pandemic, the team enrolled over 700 patients, collected thousands of samples, and have since generated a diverse set of molecular data using state-of-the-art technologies in immunology and genomics.

Now, in collaboration with the MSHS Office of Research Services (ORS), MSCIC and HIMC we are excited to announce that the Mount Sinai community can request access to the Mount Sinai COVID-19 Biobank samples and data. Requests will be fielded by the Mount Sinai COVID-19 Biobank Study Review Committee, which will serve to streamline work efforts, maintain a high quality of research, and promote a culture of resource sharing.

To find out more about Mount Sinai Clinical Intelligence Center, please click HERE.
To find out more about the Human Immune Monitoring Center, please click HERE.

  1. Charney, A.W., Simons, N.W., Mouskas, K. et al. Sampling the host response to SARS-CoV-2 in hospitals under siege. Nat Med 26, 1157–1158 (2020). https://doi.org/10.1038/s41591-020-1004-3

Recent ConduITS News

What is the Innovation Core?

The Innovation Core is a network of groups and resources that foster innovation and entrepreneurship, vital elements in training scientists to advance their discoveries from the research setting into the clinic. Mount Sinai’s Innovation Partners (MSIP), the technology...

read more

What does the Innovation Core do?

Mount Sinai’s Innovation Core is designed to fill the gap in the training and expertise needed to move a discovery from the research setting into a viable product or service that can help patients, or to recognize the potential for translation and / or...

read more

Newsletter Special Edition

Click here to view the special edition of the Conduit Newsletter, designed in CANVA! As part of a new initiative by The Mount Sinai ConduITS Institutes for Translational Sciences (CTSA), we are thrilled to introduce our latest newsletter designed to aid researchers in...

read more

Trainee Corner

Mount Sinai CTSA Featured Trainees

Megan Januska

Megan Januska

Megan Januska, MD is an Assistant Professor in the Division of Pediatric Pulmonology in the Jack and Lucy Clark Department of Pediatrics and in the Department of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai and Mount Sinai Kravis...

read more
Sangeetha Vadakke-Madathil

Sangeetha Vadakke-Madathil

Sangeetha Vadakke-Madathil, PhD, is currently a junior faculty (Instructor of Medicine) at Icahn School of Medicine at Mount Sinai, New York, NY. After receiving her Ph.D. degree in human hematopoietic stem cells and transplant biology from National Centre for Cell...

read more